Literature DB >> 5964614

Antigenicity of carcinogen-induced and spontaneous tumours in inbred mice.

H J Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5964614      PMCID: PMC2008147          DOI: 10.1038/bjc.1966.95

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  ACQUISITION OF HEIGHTENED RESISTANCE AND SUSCEPTIBILITY TO SPONTANEOUS MOUSE MAMMARY CARCINOMAS IN THE ORIGINAL HOST.

Authors:  D W WEISS; L J FAULKIN; K B DEOME
Journal:  Cancer Res       Date:  1964-05       Impact factor: 12.701

2.  COMBINATION THERAPY WITH CYCLOPHOSPHAMIDE AND ZYMOSAN ON A SPONTANEOUS MAMMARY CANCER IN MICE.

Authors:  D S MARTIN; P HAYWORTH; R A FUGMANN; R ENGLISH; H W MCNEILL
Journal:  Cancer Res       Date:  1964-05       Impact factor: 12.701

3.  IMMUNITY TO SPONTANEOUS AND METHYLCHOLANTHRENE-INDUCED TUMORS IN INBRED MICE.

Authors:  R S RIGGINS; Y H PILCH
Journal:  Cancer Res       Date:  1964-12       Impact factor: 12.701

4.  Demonstration of host resistance against isotransplantation of lymphomas induced by the Gross agent.

Authors:  G KLEIN; H O SJOGREN; E KLEIN
Journal:  Cancer Res       Date:  1962-09       Impact factor: 12.701

5.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

6.  Immunity to methylcholanthrene-induced sarcomas.

Authors:  R T PREHN; J M MAIN
Journal:  J Natl Cancer Inst       Date:  1957-06       Impact factor: 13.506

7.  Immunology of the mouse mammary tumor virus (MTV) : identification in vitro of mouse antibodies against MTV.

Authors:  P B Blair; D H Kavrin; M Dezfulian; D W Weiss
Journal:  Cancer Res       Date:  1966-04       Impact factor: 12.701

8.  Immunology of spontaneous mammary carcinomas in mice IV. Association of the mammary tumor virus with the immunogenicity of C3H nodules and tumors.

Authors:  D H Lavrin; P B Blair; D W Weiss
Journal:  Cancer Res       Date:  1966-05       Impact factor: 12.701

9.  The significance of splenomegaly in tumour-bearing mice.

Authors:  M F WOODRUFF; M O SYMES
Journal:  Br J Cancer       Date:  1962-03       Impact factor: 7.640

  9 in total
  5 in total

Review 1.  Genomic correlates of response to immune checkpoint blockade.

Authors:  Tanya E Keenan; Kelly P Burke; Eliezer M Van Allen
Journal:  Nat Med       Date:  2019-03-06       Impact factor: 53.440

2.  Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.

Authors:  David Escors
Journal:  New J Sci       Date:  2014-01-05

Review 3.  Natural Killer Cells: Development, Maturation, and Clinical Utilization.

Authors:  Alex M Abel; Chao Yang; Monica S Thakar; Subramaniam Malarkannan
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

4.  CD8+ T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity.

Authors:  Roman V Uzhachenko; Anil Shanker
Journal:  Front Immunol       Date:  2019-08-13       Impact factor: 7.561

Review 5.  Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response.

Authors:  Stephen Pierce; Eric S Geanes; Todd Bradley
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.